MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference

CEO Ofer Gonen provided an update on the company’s commercial burn franchise, late-stage chronic wound program, manufacturing expansion plans, and government-related efforts during Oppenheimer’s ...
Healio

FDA approves pediatric indication for NexoBrid for treatment of thermal burns

Please provide your email address to receive an email when new articles are posted on . NexoBrid was approved for the treatment of deep partial-thickness and full-thickness thermal burns in adults in ...
Nasdaq

MediWound Announces U.S. Commercial Availability of NexoBrid® for the Treatment of Severe Thermal Burns in Adults

Full commercial launch of NexoBrid marks important first step to becoming the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal burns YAVNE, Israel, ...
Monthly Prescribing Reference

Severe Burn Therapy NexoBrid Gets FDA Approval

Credit: Getty Images. NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes. The Food and Drug Administration (FDA) has approved ...
Monthly Prescribing Reference

NexoBrid Approval Expanded to Include Pediatric Burn Patients

NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes. The Food and Drug Administration (FDA) has expanded the approval of ...
KELOLAND News

Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults

Potential to become the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal burns Label supported by robust clinical data demonstrating significantly ...
Healio

Botanical drug may outperform standard of care for treatment of severe thermal burns

Please provide your email address to receive an email when new articles are posted on . Phase 3 data shows NexoBrid allows for the early complete eschar removal in more than 90% of patients. This ...